Rekvina Labs Share Price

Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers.The Company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. Copper Extrusion. The Company had launched a new product REKSEAL, a tissue adhesive for wound closure from the market in 19992000. Though there was persistent recessionary trend in the pharmaceutical industry there is a decrease in the turnover of the Company which affected the. net worth of the Company adversely. In 201920, there was an overall slowdown in the economy. The Company incurred losses over a couple of years. The Company is focusing on strengthening its core business of manufacturing and marketing formulations. Research and Development (RD) initiatives have been accelerated to improve cost competitiveness and ensure compliance with global regulatory requirements. Cost optimization, efficient resource utilization, and strong management control are being emphasized across all operations.

As of 21 Jan 2026, Rekvina Labs share price is ₹9. The stock opened at ₹9 and had closed at ₹8.6 the previous day. During today’s trading session, Rekvina Labs share price moved between ₹9.01 and ₹9.01, with an average price for the day of ₹9.01. Over the last 52 weeks, the stock has recorded a low of ₹6.75 and a high of ₹9.01. In terms of performance, Rekvina Labs share price has increased by 100.2% over the past six months and has increased by 15.68% over the last year.